PHCL 3700 Exam 1 Study Set
pharmaceutics - Answer the science of drugs including thier origin, composition,
pharmacokinectics, therapeutic use, and toxicology
pharmacon - Answer compounds that produce therapeutic effects
toxicon - Answer compounds that produce adverse effects without producing any
therapeutic effects
pharmacodynamics - Answer study of biochemical, cellular, and physiological effects of
drugs and their mechanism of action on the body
pharmacokinetics - Answer how drugs move into the body, distribute to various parts of
the body and how tehy are eliminated
pharmacogenomics - Answer the impact of genes on drug action
Discovery - Answer the early way to discover drugs based on observing medicinal
properties of natural sources like plants
invention - Answer the modern approach to drug development that uses a process of
synthesis, experimentation and optimization
rational drug design - Answer the development of new molecules from known molecules
Rational drug design - Answer Starting with the structure of an endogenous compound
that acts as an agonist at a receptor, medicinal chemists modify different functional
groups to improve activity, selectivity, and pharmacokinetic properties. This multi-step
process is known as?
screening - Answer screen a drug target until there is a hit at the targeted area,
increase those molecules in the system to produce desired outcome
orphan drug - Answer a drug that is for a relatviely rare disease and is usually hard to
get grants/loans for research
Investigational New Drug (IND) application - Answer A document that contains all
preclinical data on a drug, including effects on animals, chemistry and manufacturing
information, safety and pharmacokinetic data, the rationale for studies in humans and
clinical plans?
30 days - Answer How long does the FDA have to review an IND application before
clinical trials may be initiated?
acute toxicity studies - Answer the studying of what happens when a drug is given in a
short amount of time (right away), only a few doses
chronic toxicity studies - Answer studies that extend observation of a drug to multiple
, days to see if an extended period affects target better
geotoxicity - Answer the study of exposing drugs to different genes and if the drug
causes changes
maximum tolerated dosage - Answer increase dose until mild advese affects arise, could
go higher but will make that the __________?
in vitro - Answer work done not in animals but in test tubes, petri dishes
in vivo - Answer work done in animals
Phase I - Answer what phase is usually the first time a drug is given to humans in clinical
trials
Phase I - Answer the testing of a drug on a small population of people (10-100) who are
healthy
Phase I - Answer this phase emphasises the evaluation of safety of a drug
Phase II - Answer the testing of a drug on a larger population of people (50-500) who
have the disease
Phase II - Answer This phase is usually the first assessment of efficacy--> is the drug
gonna treat the intended disorder? Phase still tests for safety but emphasis on efficacy.
Usually in one area
phase III - Answer the testing of a drug on a large number of patients (200-2000) with
disease at multiple different sites and eveluates safety and efficacy
New Drug Approval (NDA) - Answer FDA reviews safety and efficacy data found in all
trials and decides that there is a balance between safety and innovation
Post Marketing Surveillance - Answer What is Phase IV also referred to as?
Phase IV - Answer study done after a drug has been approved to identify if any
uncommon adverse effects arise from a drug
Valsartan - Answer What is an example of a drug that was recalled during post
marketing surveillance because it was found to be a contaminant in generic
formulations and a threat to public safety?
FDA - Answer Responsible for protecting public healthy by assuring safety, efficacy, and
security of drugs who also have an important role in approving drugs
Pure Foods and Drugs Act of 1906 - Answer Which act focused on misbranding, or
labeling and set the requirements for labeling but did not have restriction on what was in
the medications
Pure Foods and Drugs Act of 1906 - Answer This act defined drugs as "any substance or
pharmaceutics - Answer the science of drugs including thier origin, composition,
pharmacokinectics, therapeutic use, and toxicology
pharmacon - Answer compounds that produce therapeutic effects
toxicon - Answer compounds that produce adverse effects without producing any
therapeutic effects
pharmacodynamics - Answer study of biochemical, cellular, and physiological effects of
drugs and their mechanism of action on the body
pharmacokinetics - Answer how drugs move into the body, distribute to various parts of
the body and how tehy are eliminated
pharmacogenomics - Answer the impact of genes on drug action
Discovery - Answer the early way to discover drugs based on observing medicinal
properties of natural sources like plants
invention - Answer the modern approach to drug development that uses a process of
synthesis, experimentation and optimization
rational drug design - Answer the development of new molecules from known molecules
Rational drug design - Answer Starting with the structure of an endogenous compound
that acts as an agonist at a receptor, medicinal chemists modify different functional
groups to improve activity, selectivity, and pharmacokinetic properties. This multi-step
process is known as?
screening - Answer screen a drug target until there is a hit at the targeted area,
increase those molecules in the system to produce desired outcome
orphan drug - Answer a drug that is for a relatviely rare disease and is usually hard to
get grants/loans for research
Investigational New Drug (IND) application - Answer A document that contains all
preclinical data on a drug, including effects on animals, chemistry and manufacturing
information, safety and pharmacokinetic data, the rationale for studies in humans and
clinical plans?
30 days - Answer How long does the FDA have to review an IND application before
clinical trials may be initiated?
acute toxicity studies - Answer the studying of what happens when a drug is given in a
short amount of time (right away), only a few doses
chronic toxicity studies - Answer studies that extend observation of a drug to multiple
, days to see if an extended period affects target better
geotoxicity - Answer the study of exposing drugs to different genes and if the drug
causes changes
maximum tolerated dosage - Answer increase dose until mild advese affects arise, could
go higher but will make that the __________?
in vitro - Answer work done not in animals but in test tubes, petri dishes
in vivo - Answer work done in animals
Phase I - Answer what phase is usually the first time a drug is given to humans in clinical
trials
Phase I - Answer the testing of a drug on a small population of people (10-100) who are
healthy
Phase I - Answer this phase emphasises the evaluation of safety of a drug
Phase II - Answer the testing of a drug on a larger population of people (50-500) who
have the disease
Phase II - Answer This phase is usually the first assessment of efficacy--> is the drug
gonna treat the intended disorder? Phase still tests for safety but emphasis on efficacy.
Usually in one area
phase III - Answer the testing of a drug on a large number of patients (200-2000) with
disease at multiple different sites and eveluates safety and efficacy
New Drug Approval (NDA) - Answer FDA reviews safety and efficacy data found in all
trials and decides that there is a balance between safety and innovation
Post Marketing Surveillance - Answer What is Phase IV also referred to as?
Phase IV - Answer study done after a drug has been approved to identify if any
uncommon adverse effects arise from a drug
Valsartan - Answer What is an example of a drug that was recalled during post
marketing surveillance because it was found to be a contaminant in generic
formulations and a threat to public safety?
FDA - Answer Responsible for protecting public healthy by assuring safety, efficacy, and
security of drugs who also have an important role in approving drugs
Pure Foods and Drugs Act of 1906 - Answer Which act focused on misbranding, or
labeling and set the requirements for labeling but did not have restriction on what was in
the medications
Pure Foods and Drugs Act of 1906 - Answer This act defined drugs as "any substance or